MétaCan
Menu
← Retour à la cohorte
Enregistrement W2942019040 · doi:10.1097/01.ju.0000556440.68613.6e

MP48-08 THE LONG-TERM OUTCOMES OF GRADE GROUPS 2 AND 3 PROSTATE CANCER MANAGED BY ACTIVE SURVEILLANCE: RESULTS FROM A LARGE POPULATION-BASED COHORT

2019· article· en· W2942019040 sur OpenAlexaboutno aff
P. Richard, Saint-denis de-Brampton, Narhari Timishina, Maria Komisarenko, Lisa Martin, Ardalan E. Ahmad, Shabbir M.H. Alibhai, Robert J. Hamilton, Girish S. Kulkarni, Antonio Finelli

Notice bibliographique

RevueThe Journal of Urology · 2019
Typearticle
Langueen
DomaineMedicine
ThématiqueProstate Cancer Diagnosis and Treatment
Établissements canadiensnon disponible
Organismes subventionnairesnon disponible
Mots-clésMedicineProstate cancerCancerProstatectomyCohortPopulationSAINTBrachytherapyRadiation therapyGynecologySurgeryInternal medicineArt historyHistory

Résumé

récupéré en direct d'OpenAlex

You have accessJournal of UrologyProstate Cancer: Localized: Active Surveillance I (MP48)1 Apr 2019MP48-08 THE LONG-TERM OUTCOMES OF GRADE GROUPS 2 AND 3 PROSTATE CANCER MANAGED BY ACTIVE SURVEILLANCE: RESULTS FROM A LARGE POPULATION-BASED COHORT Patrick Richard*, Saint-denis de-Brampton, Narhari Timishina, Maria Komisarenko, Lisa Martin, Ardalan Ahmad, Shabbir Alibhai, Robert Hamilton, Girish Kulkarni, and Antonio finelli Patrick Richard*Patrick Richard* More articles by this author , Saint-denis de-BramptonSaint-denis de-Brampton More articles by this author , Narhari TimishinaNarhari Timishina More articles by this author , Maria KomisarenkoMaria Komisarenko More articles by this author , Lisa MartinLisa Martin More articles by this author , Ardalan AhmadArdalan Ahmad More articles by this author , Shabbir AlibhaiShabbir Alibhai More articles by this author , Robert HamiltonRobert Hamilton More articles by this author , Girish KulkarniGirish Kulkarni More articles by this author , and Antonio finelliAntonio finelli More articles by this author View All Author Informationhttps://doi.org/10.1097/01.JU.0000556440.68613.6eAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract INTRODUCTION AND OBJECTIVES: Prostate cancer is the most common solid organ cancer among North American men. Traditionally, men diagnosed with prostate cancer were offered treatments in the form of radical prostatectomy, external-beam radiotherapy or brachytherapy. However, natural history studies have shown that only a minority of those with low or intermediate risk disease will develop metastases and/or succumb to the cancer. Thus, active surveillance has become an accepted strategy for low-risk, but debated as to its application in intermediate-risk prostate cancer. Unfortunately, most reports of intermediate-risk prostate cancer managed by active surveillance generally lack long-term follow-up and include small numbers of patients. Thus, the objective of this population-based study was to report the long-term outcomes of men diagnosed with Grade Groups 2 and 3 prostate cancer who were managed expectantly. METHODS: Using administrative datasets and pathology reports, we identified all men who were diagnosed with Grade Groups 2 and 3 prostate cancer and managed expectantly between 2002 and 2011 in Ontario, Canada. The overall survival, cancer-specific survival and treatment-free survival were estimated using cumulative incidence function methods while their associated factors were estimated multivariable Cox regression models. RESULTS: We identified 926 men with GG2 or GG3 PCa that were managed expectantly (active surveillance (n=374) or watchful waiting (n=552)). The 8-year cancer-specific survival was 94% and 89% for the active surveillance and watchful waiting cohorts, respectively. Among men managed by active surveillance, 266 (71%) received treatment after a follow-up of approximately 8 years. Cumulative active surveillance discontinuation rates at 1- and 5-years were 30.5% and 65.1%, respectively. CONCLUSIONS: Expectant management of Grade Groups 2 and 3 PCa may be an option for certain men. Notably for active surveillance patients, the cancer-specific mortality at 8-years was 6%. More importantly, over 65% of men underwent treatment within 5 years. Further studies are required to evaluate which sub-group of patients, based on disease-specific features and competing health risks, would benefit the most from this strategy. Source of Funding: Prostate Cancer Canada Qc, Canada; Toronto, Canada© 2019 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 201Issue Supplement 4April 2019Page: e699-e700 Advertisement Copyright & Permissions© 2019 by American Urological Association Education and Research, Inc.MetricsAuthor Information Patrick Richard* More articles by this author Saint-denis de-Brampton More articles by this author Narhari Timishina More articles by this author Maria Komisarenko More articles by this author Lisa Martin More articles by this author Ardalan Ahmad More articles by this author Shabbir Alibhai More articles by this author Robert Hamilton More articles by this author Girish Kulkarni More articles by this author Antonio finelli More articles by this author Expand All Advertisement PDF downloadLoading ...

Récupéré en direct depuis OpenAlex et désinversé. Les résumés ne sont pas conservés dans cette base de données : les index inversés représentent 8,6 Go des 9,3 Go de texte de la base, et le serveur dispose de 13 Go libres.

Comment cette classification a été obtenuedéplier

Prédiction machine sur la base complète

Imitation des enseignants

Ni prévalence calibrée, ni vérité terrain. Validation humaine à venir. Le volet Gemma est une étiquette directe du modèle pour chaque travail de la base, lue sur la notice réduite au titre. Le volet Codex est un classifieur appris des 10 348 étiquettes directes de Codex et calibré sur les taux pondérés de l'échantillon; les champs sans appui suffisant ne portent aucun appel Codex. Le mode candidate est l'union des deux volets; le consensus est leur intersection. Ces sorties portent le statut machine_predicted_unvalidated et ne sont pas des étiquettes humaines.

score de la tête « metaresearch » (Codex)0,001
score de la tête « metaresearch » (Gemma)0,005
Version: metacan-v3-hybrid-931329e0061cStatut de validation: machine_predicted_unvalidated
Catégories candidatesaucune
Catégories consensuellesaucune
DomaineSignal candidat: aucune · Signal consensuel: aucune
Devis d'étudeSignal candidat: Observationnel · Signal consensuel: Observationnel
GenreSignal candidat: Empirique · Signal consensuel: Empirique
Score de désaccord entre enseignants0,006
Score d'incertitude au seuil0,021

Scores du classifieur distillé par catégorie (deux têtes)

CatégorieCodexGemma
Métarecherche0,0010,005
Méta-épidémiologie (sens strict)0,0000,000
Méta-épidémiologie (sens large)0,0000,001
Bibliométrie0,0010,001
Études des sciences et des technologies0,0000,000
Communication savante0,0010,001
Science ouverte0,0010,001
Intégrité de la recherche0,0010,001
Charge utile insuffisante (le modèle a refusé de juger)0,0060,003

Scores machine (provisoires)

Les deux têtes enseignantes du modèle étudiant, lues sur ce travail. Un score ordonne la base pour la relecture; il n'affirme jamais une catégorie, et le statut de validation accompagne chaque rangée tel quel.

Scores de référence d'un modèle non mature (critères de maturité non atteints, 7 itérations). Un score ordonne; il n'affirme jamais une catégorie.

Tête enseignante Opus0,012
Tête enseignante GPT0,282
Écart entre enseignants0,271 · la distance entre les deux têtes enseignantes sur ce seul travail
Statut de validationscore_only:v0-immature-baseline · tel quel depuis la passe de notation : score_only signifie que le nombre peut ordonner les travaux, et qu'aucune étiquette de catégorie n'en découle

Classification

machine, non validée

Prédiction automatique; un appel candidat d’une seule source (Gemma direct ou Codex distillé), pas un consensus.

Les modèles n’ont appliqué aucune catégorie : rien dans la taxonomie ne correspondait à ce travail.
Devis d'étudeObservationnel
Domainenon disponible
GenreEmpirique

Le détail, modèle par modèle et score par score, se trouve en fin de page sous « Comment cette classification a été obtenue ».

En bref

Citations0
Publié2019
Routes d'admission1
Résumé présentoui

Explorer davantage

Même revueThe Journal of Urology→Même sujetProstate Cancer Diagnosis and Treatment→Travaux en français237 207→